UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000031621
Receipt No. R000036095
Scientific Title Retrospective analysis of randomized phase II trial (WJOG6210G) of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in patients with KRAS wild metastatic colorectal cancer refractory to oxaliplatin and bevacizumab to evaluate the association of survival time and treatment efficacy (early tumor shrinkage, depth of response and best overall response) at each arm
Date of disclosure of the study information 2018/03/07
Last modified on 2018/04/12 10:29:38

No. Disposal Last modified on Item of update
1 Insert 2018/03/07 11:13:30
2 Update 2018/04/12 10:29:38 Recruitment status
Anticipated trial start date

Contact us.